- Market Size (2026)
- USD 603.2 Mn
- Forecast (2036)
- USD 1020.7 Mn
- CAGR (2026 to 2036)
- 5.4%
How big is Dimethyl Sulfoxide (DMSO) Market in 2026?
The dimethyl sulfoxide (DMSO) market is estimated at USD 572.3 million in 2025 and is projected to reach USD 603.2 million in 2026. Dimethyl sulfoxide (DMSO) sales are expected to grow at a 5.4% CAGR between 2026 and 2036 and reach USD 1,020.7 million by 2036.
Demand for dimethyl sulfoxide (DMSO) is estimated at USD 572.3 million in 2025 and is projected to increase to USD 603.2 million in 2026, and sales are projected to grow to USD 1,020.7 million by 2036 on a 5.4% CAGR. The dimethyl sulfoxide (DMSO) outlook is shifting toward high-purity grades, and purer DMSO for photoresist stripping and wafer cleaning will set the direction of the decade. Global semiconductor sales passed USD 1 trillion in the first eight months of 2026, and August sales of USD 159.7 billion were 144.3% above August 2025, SIA reported.[1] Every new 300 mm wafer line needs strippers and cleaners with metal traces at parts-per-billion levels, so electronic grade sells at a clear premium over bulk solvent and adds value faster than volume. FMI's analysts advise DMSO producers to qualify a dedicated electronic-grade train with chip makers in the United States, Germany and South Korea before new fabs reach volume, since a fab rarely changes a qualified solvent during the life of a process node.
Key Market Trends & Insights
- Industrial DMSO, bought in drums and tankers as reaction and spinning solvent by drug, crop chemical and fibre plants, is expected to hold 52.4% of grade sales in 2026.
- Drug makers use DMSO at two production stages, and pharmaceutical use is likely to lead applications with 38.6% in 2026; chemicals and agrochemicals follow at an estimated 22.4%. India has set up 55,100 tonnes a year of capacity for 26 critical APIs and key starting materials under the bulk drug PLI scheme.[2]
Regional Highlights
- India is first among the countries covered at a 7% CAGR, as API makers add capacity under the bulk drug PLI scheme.
- China follows with 6.5% on electronics and crop chemicals, and South Korea grows close to the global figure at 5.3%. The four Western and Japanese markets fall between 4.8% and 5.2%.
- South Korean exports reached USD 120.9 billion in September 2026, and chip exports grew 263% to USD 60.3 billion, the trade ministry said.[3]
Market Size & Forecast
Table 1: Market Size and Forecast for the Dimethyl Sulfoxide (DMSO) Market (USD million and percentage), 2025 to 2036
| Metric | Value |
|---|---|
| 2025 Market Size | USD 572.3 million |
| Estimated Market Size in 2026 | USD 603.2 million |
| Projected Market Size by 2036 | USD 1,020.7 million |
| CAGR, 2026 to 2036 | 5.4% |
| Added Revenue, 2026 to 2036 | USD 417.5 million |
| Market Expansion Multiple | 1.7x |
Drug makers, chip fabs and crop chemical formulators buy DMSO on annual or quarterly supply agreements, and order volume follows API batches, wafer starts and spraying seasons. gChem makes millions of pounds of DMSO a year at one integrated plant in Alabama and is the only producer in the Western Hemisphere, FM reported in April 2026.[4] With a single site, North American buyers hold safety stock against any outage. DMDS shares the methyl sulfur chemistry and several producers with DMSO, and refinery sulfiding work holds the dimethyl disulphide (DMDS) market to a projected 4.2%, a little under the dimethyl sulfoxide (DMSO) market. FMI's model shows dimethyl sulfoxide (DMSO) sales increasing by USD 417.5 million over the decade, and the 2036 figure is expected to be close to 1.7 times the 2026 level. An unplanned shutdown at one of the few large plants is the main risk, since pharmaceutical and electronic grades need months to requalify.
Grade Purity, Fab Build-Out and Cell Therapy Media
New fabs are adding the largest blocks of new demand for electronic grade. GlobalFoundries was selected to run two fabs in Malta, New York, under the U.S.-Japan Strategic Investment Initiative, with up to USD 21 billion of investment and about 900,000 300 mm wafers a year of capacity from the first fab, SIA said on 14 October 2026.[5] ESMC is building a 40,000-wafer-a-month fab in Dresden with overall investment expected above EUR 10 billion.[6] Strippers are a main outlet for electronic-grade DMSO, and each new wafer line keeps the photoresist stripper market on an expected 5.3% CAGR. The FMI outlook gives electronic grade the quickest growth of the three grades.
Cell therapy is the fastest-moving pharmaceutical use. Repligen agreed in July 2026 to acquire BioLife Solutions for about USD 1.5 billion, and the BioLife CryoStor media is used in 18 commercially approved cell therapies.[7] Cryopreservation media for cell therapies commonly use DMSO to protect cells during freezing. BioLife reported Q2 2026 revenue of USD 28.5 million, 21% higher than a year earlier, and said the media is used in about 250 commercially sponsored clinical trials.[8] Growth in the cell culture media market is forecast at a 6.6% CAGR, and more cultured cells mean more frozen doses that need cryoprotectant.
Table 2: Fab, Pharmaceutical and Supply Indicators for the Dimethyl Sulfoxide (DMSO) Market (sales, capacity and investment), 2026
| Indicator | Data Point | Relevance | Source |
|---|---|---|---|
| Global semiconductor sales, August 2026 | USD 159.7 billion; up 144.3% | Wafer starts drive electronic-grade orders. | [1] |
| GlobalFoundries Malta fabs | Up to USD 21 billion; about 900,000 wafers a year from fab one | New US demand for stripping solvents. | [5] |
| ESMC Dresden fab | 40,000 wafers a month; above EUR 10 billion | Demand for electronic grade in Europe. | [6] |
| BioLife Q2 2026 revenue | USD 28.5 million; up 21% | Cell therapy freezing media grow. | [8] |
| India bulk drug PLI capacity | 55,100 tonnes a year for 26 APIs and KSMs | More API synthesis solvent use. | [2] |
| South Korea chip exports, September 2026 | USD 60.3 billion; up 263% | Korean fabs run at high utilisation. | [3] |
Analyst Perspective
“I expect purity to deliver most of the new margin in DMSO, as chip fabs and cell therapy makers pay for grades that bulk solvent buyers never ask for. Producers holding pharmaceutical and electronic qualifications at two or more sites will keep those customers through every supply scare to 2036.”
- Nikhil Kaitwade, Principal Consultant, Future Market Insights.
How is the dimethyl sulfoxide (DMSO) market segmented?
The market is segmented into grade, application, and region. Industrial grade is expected to lead grade sales with 52.4% share in 2026, and pharmaceuticals lead application with 38.6%.
By grade: pharmaceutical grade, industrial grade, and electronic grade.
By application: pharmaceuticals, chemicals and agrochemicals, electronics, polymer processing, paints and coatings, and others.
By region: drug, chip, crop chemical and fibre plants in North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia and Pacific, and Middle East and Africa.
Why does industrial grade lead dimethyl sulfoxide (DMSO) sales by grade?
Bulk solvent buyers keep industrial grade ahead in 2026 at an expected 52.4% of grade sales, with pharmaceutical grade near 36.8% and electronic grade near 10.8%.
Table 3: Grade Share for the Dimethyl Sulfoxide (DMSO) Market (percentage share), 2026
| Grade | Estimated Share (2026) |
|---|---|
| Industrial Grade | 52.4% |
| Pharmaceutical Grade | 36.8% |
| Electronic Grade | 10.8% |
| Total | 100.0% |
Table 4: Grade Leadership and Market Growth for the Dimethyl Sulfoxide (DMSO) Market (segment and CAGR percentage), 2026 to 2036
| Metric | Value |
|---|---|
| Global CAGR (2026 to 2036) | 5.4% |
| Leading Segment | Industrial Grade |
Bought by the tonne for synthesis, formulation and spinning, industrial grade is expected to lead with 52.4% share in 2026. Against pharmaceutical grade, near 36.8%, industrial DMSO is bought by the tonne for API synthesis, crop chemical formulation, acrylic fibre spinning and paint stripping, and none of those uses needs a drug master file or sterile packing. Pharmaceutical grade earns more per kilogram in injectables, topical products and cell freezing media, and gChem refines that grade to 99.99% purity under federal supervision.[4] Against electronic grade, an estimated 10.8%, industrial DMSO is far cheaper and free of metal-trace testing, and electronic grade serves only fabs and display plants. India has built 55,100 tonnes a year of API and starting material capacity under the bulk drug PLI scheme, and each synthesis step there uses industrial solvent.[2] A formulator buying DMSO as a reaction medium will keep choosing industrial grade, and only a product entering the body or a wafer justifies a purer lot.
- Reaction solvent for APIs and crop chemicals, acrylic fibre spinning and stripping uses form the industrial grade base.
- gChem lists medicines, semiconductor manufacturing, carbon fibre production and fertilizer stabilisation among DMSO uses, FM reported on 5 April 2026.[4]
Why do pharmaceuticals lead dimethyl sulfoxide (DMSO) sales by application?
Pharmaceuticals are likely to account for 38.6% of application sales in 2026, with chemicals and agrochemicals at about 22.4% and electronics at roughly 14.7%.
Table 5: Application Share for the Dimethyl Sulfoxide (DMSO) Market (percentage share), 2026
| Application | Estimated Share (2026) |
|---|---|
| Pharmaceuticals | 38.6% |
| Chemicals and Agrochemicals | 22.4% |
| Electronics | 14.7% |
| Polymer Processing | 10.2% |
| Paints and Coatings | 7.3% |
| Others | 6.8% |
| Total | 100.0% |
With drug makers using DMSO twice, first as industrial solvent in API synthesis and then as pharmaceutical grade in finished products and freezing media, pharmaceuticals are projected to lead with 38.6% share in 2026. Those two stages give pharmaceuticals the application lead next to an industrial lead in grades. Chemicals and agrochemicals, near 22.4%, use DMSO to dissolve active ingredients, and Corteva grew Crop Protection net sales 3% to USD 3,729 million over January to June 2026 on demand for new products.[9] Electronics, about 14.7%, buys the smallest volumes at the highest prices. Polymer processing, an estimated 10.2%, uses DMSO to spin acrylic and carbon fibre precursors. Paints and coatings, near 7.3%, use DMSO as a safer stripper, and demand for safer cleaning solvents supports a 4.8% CAGR forecast for the industrial cleaning solvent market. Other uses, including cell freezing and personal care, account for 6.8%. Drug makers will keep the largest DMSO budgets, since one product can need the solvent at two stages.
- API synthesis, topical formulations, injectables and cell cryopreservation make up the pharmaceutical group.
- Repligen agreed on 22 July 2026 to buy BioLife Solutions, whose CryoStor media is used in 18 approved cell therapies.[7]
What are the drivers, restraints, and opportunities in the dimethyl sulfoxide (DMSO) market?
Drug synthesis, cell therapy and chip production all need a polar solvent with low toxicity, which keeps DMSO in demand across very different buyers. Supply from few plants limits buyer choice, and new fabs open a premium grade.
- Driver: Drug makers and cell therapy developers rely on DMSO as a low-toxicity solvent and cryoprotectant, so each new API line or therapy adds steady orders.
- Restraint: Production is concentrated in a few large plants, which exposes buyers to outages and slows the qualification of new sources.
- Opportunity: New fabs need ultra-pure stripping and cleaning solvents, giving producers with electronic-grade purification a high-margin outlet.
API and Cell Therapy Growth Keep Orders Steady
Drug plants are replacing more toxic solvents with DMSO, and API growth adds to that volume. India exported USD 30.5 billion of pharmaceuticals in 2024-25, and about 500 API makers account for nearly 8% of the global API industry, the government said in March 2026.[2] BioLife said in August 2026 that the media franchise is embedded in 18 commercial cell and gene therapies.[8] API plants and cell therapy sites will add DMSO orders with each approved product.
Concentrated Supply Raises Buyer Risk
Producers of DMSO are few, and one plant outage can tighten a whole region. gChem operates one fully integrated site with no backup facility and runs an annual maintenance shutdown, FM reported.[4] Chinese and European plants supply most other volume, so buyers in North America face long requalification after any gChem stoppage. Drug and chip customers will pay for dual qualification, and producers without a second site will face that request in every contract round.
New Fabs Open a Premium Electronic Grade
Adoption of DMSO-based strippers is growing as fabs move away from harsher solvents. South Korean chip exports grew 263% to USD 60.3 billion in September 2026.[3] Purchases of wafer chemicals follow fab output, and the semiconductor process chemicals market is forecast to expand at an 11.8% CAGR. Producers with sub-ppb metal purification will gain fab qualifications that bulk suppliers cannot match, securing the next leg of growth for electronic-grade solvent.
Which country CAGRs are profiled in the dimethyl sulfoxide (DMSO) market?
Table 6: Country CAGR Comparison for the Dimethyl Sulfoxide (DMSO) Market (CAGR percentage), 2026 to 2036
| Country | CAGR (2026 to 2036) |
|---|---|
| India | 7% |
| China | 6.5% |
| South Korea | 5.3% |
| United States | 5.2% |
| United Kingdom | 4.9% |
| Germany | 4.8% |
| Japan | 4.8% |
How do country-level CAGRs compare in the dimethyl sulfoxide (DMSO) market?
India counts about 500 API manufacturers, and new bulk drug capacity under the PLI scheme gives the country a 7% CAGR, per FMI's model.[2] China grows at 6.5% on crop chemical formulation and electronics. Chip exports keep South Korea within a tenth of a point of the world rate, at 5.3%. The United States grows at 5.2%, short of the 5.4% dimethyl sulfoxide (DMSO) market rate, as new fabs only partly offset mature pharmaceutical use. The United Kingdom, at 4.9%, relies on cell therapy and research buyers. Germany and Japan grow at 4.8% each, held back by mature chemical industries and slow drug volume growth.
- New API plants under the PLI scheme drive India.
- Crop chemical and electronics plants carry demand in China.
- Korean memory fabs buy electronic grade.
- The only Western Hemisphere producer supplies American buyers.
- Cell therapy developers set the British pace.
- A new Dresden fab adds demand for electronic grade in Germany.
- Japanese drug and display plants buy steady, mature volumes.
Full report country CAGRs cover: Drug synthesis and crop chemicals put India and China at the top, South Korea and the United States are close to the 5.4% global rate, and the United Kingdom, Germany and Japan grow more slowly. Eastern Europe, Latin America and Middle East and Africa appear in the full report at regional level.
Country-wise Analysis
India Dimethyl Sulfoxide (DMSO) Market Outlook (2026 to 2036)
Under the bulk drug PLI scheme, India has set up 55,100 tonnes a year of capacity for 26 critical APIs and key starting materials, and investment reached Rs 4,763.34 crore against a Rs 4,329.95 crore target by September 2025.[2] Each new API line uses the solvent in synthesis and purification, so Indian demand for dimethyl sulfoxide (DMSO) is projected to grow at a 7% CAGR.
Key takeaway: New API plants make India the fastest DMSO market.
China Dimethyl Sulfoxide (DMSO) Market Outlook (2026 to 2036)
Chinese producers such as Hubei Xingfa and Shandong Haike supply domestic crop chemical, fibre and electronics plants, and on that domestic offtake, a 6.5% CAGR is forecast for China. Chip sales in China grew 131.3% in August 2026 against August 2025, SIA said.[1] Domestic fabs and display plants are buying more electronic-grade DMSO from local purifiers.
Key takeaway: Electronics and crop chemicals carry China at 6.5%.
South Korea Dimethyl Sulfoxide (DMSO) Market Outlook (2026 to 2036)
Chip exports from South Korea passed USD 60 billion in a single month for the first time in September 2026.[3] The FMI outlook gives South Korea a 5.3% CAGR, as memory fabs buy electronic-grade solvent for stripping and cleaning. Display plants add a second buyer group.
Key takeaway: Memory fabs keep South Korea near the global rate.
United States Dimethyl Sulfoxide (DMSO) Market Outlook (2026 to 2036)
A 5.2% CAGR is projected for the United States. GlobalFoundries plans to break ground on the first of two Malta fabs later in 2026, and the first fab will add about 900,000 300 mm wafers a year of US capacity.[5] gChem supplies American drug, chip and crop chemical makers from one Alabama site.[4] Cell therapy developers add steady pharmaceutical-grade orders.
Key takeaway: New fabs and one domestic producer shape the American outlook.
United Kingdom Dimethyl Sulfoxide (DMSO) Market Outlook (2026 to 2036)
British cell and gene therapy developers and university laboratories buy small lots of pharmaceutical and reagent grade DMSO, and the country has no large DMSO plant. FMI's model shows the United Kingdom at a 4.9% CAGR, with orders rising as more therapies move from trials to commercial supply.
Key takeaway: Cell therapy buyers carry demand in the United Kingdom.
Germany Dimethyl Sulfoxide (DMSO) Market Outlook (2026 to 2036)
ESMC, the TSMC, Bosch, Infineon and NXP joint venture, is building a 300 mm fab in Dresden for 28/22 nm and 16/12 nm processes.[6] Germany is forecast at a 4.8% CAGR, as the new fab adds demand for electronic grade and mature chemical and drug plants grow slowly.
Key takeaway: A new fab offsets slow orders from German chemical plants.
Japan Dimethyl Sulfoxide (DMSO) Market Outlook (2026 to 2036)
Japanese chip sales grew 62.3% in August 2026 against a year earlier, the slowest of the five regions SIA tracks.[1] Japan is projected at a 4.8% CAGR, held back by mature drug and display industries. Toray Fine Chemicals and Tokyo Chemical Industry supply domestic users.
Key takeaway: Mature industries put Japan level with Germany at the bottom of the table.
Who are the notable companies in the dimethyl sulfoxide (DMSO) market?
gChem, Toray Fine Chemicals, Arkema, Hubei Xingfa, Shandong Haike, Jiangsu Jiuyi, Zibo Huixin, Yichang Xinhua, IRO Group, Charkit Chemical, Spectrum Chemical, Hefei TNJ and Tokyo Chemical Industry are the profiled companies.
FMI profiles thirteen companies, from integrated producers to distributors and laboratory suppliers. gChem produces DMSO only and earned FM Highly Protected Risk status in 2024 and 2025.[4] Arkema reported 7.4% higher EBITDA of EUR 391 million for April to June 2026 and named batteries and electronics among growth pockets.[10] Toray Fine Chemicals and Hubei Xingfa are the other large producers, and Chinese specialists, distributors and laboratory suppliers complete the group.
- Integrated producers: gChem, Toray Fine Chemicals, Arkema and Hubei Xingfa.
- Chinese specialty producers: Shandong Haike, Jiangsu Jiuyi, Zibo Huixin and Yichang Xinhua.
- Distributors and laboratory suppliers: IRO Group, Charkit Chemical, Spectrum Chemical, Hefei TNJ and Tokyo Chemical Industry.
Competitive Benchmarking: Dimethyl Sulfoxide (DMSO) Market
Table 7: Competitive Benchmarking for the Dimethyl Sulfoxide (DMSO) Market (qualitative documentation ratings), 2026
| Company | Pharmaceutical Grade | Electronic Grade | Supply Security | Recency |
|---|---|---|---|---|
| gChem | High | High | Medium | High |
| Arkema | Medium | Medium | High | High |
| Toray Fine Chemicals | High | Medium | Medium | Low |
| Hubei Xingfa | Low | Medium | Medium | Low |
| Spectrum Chemical | Medium | Low | Low | Low |
The FMI table grades each capability by the number of dated releases and third-party reports on that capability, and gives no share position.
Key Developments in the Dimethyl Sulfoxide (DMSO) Market
- On 14 October 2026, SIA welcomed GlobalFoundries as operator of two new fabs in Malta, New York.[5]
- On 5 October 2026, SIA reported that global chip sales passed USD 1 trillion through August.[1]
- On 1 October 2026, South Korea reported September chip exports of USD 60.3 billion.[3]
- BioLife Solutions, a maker of cell freezing media, had USD 28.5 million of revenue in the June 2026 quarter, results issued on 6 August 2026 showed.[8]
- Arkema's April to June 2026 EBITDA reached EUR 391 million, per the group's release of 30 July 2026.[10]
- On 30 July 2026, Corteva announced first-half Crop Protection net sales of USD 3,729 million.[9]
- On 22 July 2026, Repligen agreed to acquire BioLife Solutions for about USD 1.5 billion.[7]
- On 5 April 2026, FM published a review of risk engineering at the gChem DMSO plant in Alabama.[4]
- On 21 March 2026, the Government of India published API and bulk drug PLI capacity data.[2]
- On 28 January 2026, ESMC completed the topping-out of the office buildings at the Dresden fab site.[6]
Key Players in the Dimethyl Sulfoxide (DMSO) Market
Integrated Producers
- gChem
- Toray Fine Chemicals
- Arkema
- Hubei Xingfa
Chinese Specialty Producers
- Shandong Haike
- Jiangsu Jiuyi
- Zibo Huixin
- Yichang Xinhua
Distributors and Laboratory Suppliers
- IRO Group
- Charkit Chemical
- Spectrum Chemical
- Hefei TNJ
- Tokyo Chemical Industry
Dimethyl Sulfoxide (DMSO) Market - Report Scope
Table 8: Report Scope for the Dimethyl Sulfoxide (DMSO) Market (coverage fields and definitions), 2026 to 2036
| Coverage field | Report scope |
|---|---|
| Market breakdown | Grade; application; region |
| Quantitative units | USD million |
| Market definition | Dimethyl sulfoxide sold as industrial, pharmaceutical and electronic grade solvent, reagent and cryoprotectant for drug, crop chemical, electronics, fibre, coating and other uses. |
| Regions covered | North America; Latin America; Western Europe; Eastern Europe; East Asia; South Asia and Pacific; Middle East and Africa |
| Countries covered | United States; Canada; Brazil; Mexico; Argentina; Chile; Germany; France; United Kingdom; Italy; Spain; Benelux; Nordics; Poland; Czech Republic; Romania; Hungary; China; Japan; South Korea; India; ASEAN; Australia and New Zealand; GCC Countries; South Africa; Türkiye; Israel |
| Key companies profiled | gChem, Toray Fine Chemicals, Arkema, Hubei Xingfa, Shandong Haike, Jiangsu Jiuyi, Zibo Huixin, Yichang Xinhua, IRO Group, Charkit Chemical, Spectrum Chemical, Hefei TNJ, Tokyo Chemical Industry |
| Forecast period | 2026 to 2036 |
Dimethyl Sulfoxide (DMSO) Market - Research Methodology
Table 9: Research Methodology for the Dimethyl Sulfoxide (DMSO) Market (research methods and approach), 2026 edition
| Method | Approach |
|---|---|
| Data Sources | Producer and buyer company releases, SEC filings, semiconductor and trade association releases, government notes and trade press from May 2025 onward. |
| Desk Research | Desk research covers DMSO producers, fab construction, API capacity, cell therapy media and crop chemical sales. |
| Market Sizing and Forecasting | Sizing starts from the 2026 base of USD 603.2 million and the 5.4% CAGR for the forecast decade. |
| Data Validation | Sales, capacity and investment figures were matched to the company, agency or publication that released each one. |
Dimethyl Sulfoxide (DMSO) Market by Segments
Dimethyl Sulfoxide (DMSO) Market segmented by Grade:
- Pharmaceutical Grade
- Industrial Grade
- Electronic Grade
Dimethyl Sulfoxide (DMSO) Market segmented by Application:
- Pharmaceuticals
- Chemicals and Agrochemicals
- Electronics
- Polymer Processing
- Paints and Coatings
- Others
Dimethyl Sulfoxide (DMSO) Market by Region
- North America
- United States
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Chile
- Western Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Benelux
- Nordics
- Eastern Europe
- Poland
- Czech Republic
- Romania
- Hungary
- East Asia
- China
- Japan
- South Korea
- South Asia and Pacific
- India
- ASEAN
- Australia and New Zealand
- Middle East and Africa
- GCC Countries
- South Africa
- Türkiye
- Israel
Research Sources and Bibliography
- [1] Semiconductor Industry Association. (2026, October 5). Year-to-date global semiconductor sales top $1 trillion through August. https://www.semiconductors.org/year-to-date-global-semiconductor-sales-top-1-trillion-through-august/
- [2] Press Information Bureau, Government of India. (2026, March 21). India's pharmaceuticals in global healthcare: from domestic production to international markets. https://static.pib.gov.in/WriteReadData/specificdocs/documents/2026/mar/doc2026321831401.pdf
- [3] The Korea Times. (2026, October 1). Korea's September exports hit record $120.9 bil. on robust chip sales. https://www.koreatimes.co.kr/economy/20261001/koreas-monthly-exports-hit-1209-bil-in-sept-on-record-chip-sales
- [4] FM. (2026, April 5). gChem: Safeguarding a single essential molecule. https://www.fm.com/insights/gchem-safeguarding-a-single-essential-molecule
- [5] Semiconductor Industry Association. (2026, October 14). SIA applauds GlobalFoundries expansion under U.S.-Japan initiative. https://www.semiconductors.org/sia-applauds-globalfoundries-expansion-under-u-s-japan-initiative/
- [6] Evertiq. (2026, January 28). ESMC holds topping-out ceremony at Dresden fab site. https://evertiq.com/design/2026-01-28-esmc-holds-topping-out-ceremony-at-dresden-fab-site
- [7] BioPharm International. (2026, July 23). Repligen to acquire BioLife Solutions in $1.5 billion cell therapy deal. https://www.biopharminternational.com/view/repligen-biolife-solutions-acquisition-cell-therapy
- [8] BioLife Solutions, Inc. (2026, August 6). Exhibit 99.1: BioLife Solutions reports second quarter 2026 financial results (Form 8-K). https://www.sec.gov/Archives/edgar/data/0000834365/000162828026054288/q22026earningsrelease.htm
- [9] Corteva, Inc. (2026, July 30). Exhibit 99.1: Corteva delivers strong 1H 2026, raises FY 2026 outlook (Form 8-K). https://www.sec.gov/Archives/edgar/data/0001755672/000175567226000022/a2q_2026xearningsxnewsxr.htm
- [10] Arkema. (2026, July 30). Second-quarter 2026 results. https://www.arkema.com/global/en/media/newslist/news/global/investorrelations/2026/20260730--second-quarter-2026-results/
This bibliography is provided for reader reference. The full report contains the complete reference list and detailed citations.
This Report Answers
- How big is the dimethyl sulfoxide (DMSO) market during 2026?
- What market size is projected by 2036?
- Which grade holds notable share?
- Which application holds notable share?
- Which countries have notable growth?
- Which companies are notable in the market?
Frequently Asked Questions
How large is the dimethyl sulfoxide (DMSO) market expected in 2026?
Dimethyl sulfoxide (DMSO) sales of USD 603.2 million are expected in 2026 in FMI sizing, after an estimated USD 572.3 million in 2025. The dimethyl sulfoxide (DMSO) market is projected to reach USD 1,020.7 million by 2036.
What CAGR is projected for the dimethyl sulfoxide (DMSO) market through 2036?
Demand for dimethyl sulfoxide (DMSO) is projected to rise at a 5.4% CAGR, carried by API synthesis, cell therapy freezing media and chip fab solvents. Pharmaceutical and electronic grades add the most value.
Which grade holds a notable market share in 2026?
The leading grade in 2026 is industrial, with an expected 52.4% share. Pharmaceutical grade follows at an estimated 36.8%.
Which application holds a notable market share in 2026?
Pharmaceuticals are likely to hold 38.6% of application sales in 2026. Chemicals and agrochemicals follow at about 22.4%.
Which country has a notable expansion outlook through 2036?
New API plants give India the strongest outlook in the FMI country table, a 7% CAGR. China follows at 6.5%.
Who are the key companies in the dimethyl sulfoxide (DMSO) market?
gChem, Toray Fine Chemicals, Arkema and Hubei Xingfa are the integrated producers. Shandong Haike, Jiangsu Jiuyi, Zibo Huixin, Yichang Xinhua, IRO Group, Charkit Chemical, Spectrum Chemical, Hefei TNJ and Tokyo Chemical Industry complete the list.
Preview the report firsthand - request a free sample
Get SampleGet the brochure for pricing and purchase details.
Get PDFTable of Content
- Key Takeaways
- Market Size and CAGR
- Top Growth Driver
- Fastest Growing Segment
- Leading Region
- Key Companies
- Emerging Opportunities
- Executive Summary
- Global Market Outlook
- Demand-side Trends
- Supply-side Trends
- Technology Roadmap Analysis
- Analysis and Recommendations
- Analyst Perspective (What is happening? Why now? What should investors know?)
- Key Questions Answered
- How large is the market?
- What is the CAGR?
- What are key trends?
- Which region dominates?
- Who are the leaders?
- Market Overview
- Market Coverage / Taxonomy
- Market Definition / Scope / Limitations
- Research Methodology
- Chapter Orientation
- Analytical Lens and Working Hypotheses
- Market Structure, Signals, and Trend Drivers
- Benchmarking and Cross-market Comparability
- Market Sizing, Forecasting, and Opportunity Mapping
- Research Design and Evidence Framework
- Desk Research Programme (Secondary Evidence)
- Expert Input and Fieldwork (Primary Evidence)
- Tooling, Models, and Reference Databases
- Data Engineering and Model Build
- Quality Assurance and Audit Trail
- Market Background
- Market Dynamics (Drivers, Restraints, Opportunity, Trends)
- Scenario Forecast (Optimistic, Likely, Conservative)
- Impact Analysis
- AI Impact
- Sustainability Impact
- Regulatory Impact
- Technology Impact
- Consumer / Buyer Analysis
- Purchase Drivers
- Adoption Barriers
- Buyer Journey
- Opportunity Map Analysis
- Product Life Cycle Analysis
- Supply Chain Analysis
- Investment Feasibility Matrix
- Value Chain Analysis
- PESTLE and Porter's Analysis
- Regulatory Landscape
- Regional Parent Market Outlook
- Production and Consumption Statistics
- Import and Export Statistics
- Global Market Analysis and Forecast, 2021 to 2036
- Historical Market Size Value (USD Million) Analysis, 2021 to 2025
- Current and Future Market Size Value (USD Million) Projections, 2026 to 2036
- Y-o-Y Growth Trend Analysis
- Absolute $ Opportunity Analysis
- Global Market Pricing Analysis, 2021 to 2036
- Global Market Analysis and Forecast, By Grade, 2021 to 2036
- Introduction / Key Findings
- Historical Market Size Value (USD Million) Analysis By Grade, 2021 to 2025
- Current and Future Market Size Value (USD Million) Analysis and Forecast By Grade, 2026 to 2036
- Pharmaceutical Grade
- Industrial Grade
- Electronic Grade
- Y-o-Y Growth Trend Analysis By Grade, 2021 to 2025
- Absolute $ Opportunity Analysis By Grade, 2026 to 2036
- Global Market Analysis and Forecast, By Application, 2021 to 2036
- Introduction / Key Findings
- Historical Market Size Value (USD Million) Analysis By Application, 2021 to 2025
- Current and Future Market Size Value (USD Million) Analysis and Forecast By Application, 2026 to 2036
- Pharmaceuticals
- Chemicals and Agrochemicals
- Electronics
- Polymer Processing
- Paints and Coatings
- Others
- Y-o-Y Growth Trend Analysis By Application, 2021 to 2025
- Absolute $ Opportunity Analysis By Application, 2026 to 2036
- Global Market Analysis and Forecast, By Region, 2021 to 2036
- Introduction
- Historical Market Size Value (USD Million) Analysis By Region, 2021 to 2025
- Current Market Size Value (USD Million) Analysis and Forecast By Region, 2026 to 2036
- North America
- Latin America
- Western Europe
- Eastern Europe
- East Asia
- South Asia and Pacific
- Middle East and Africa
- Market Attractiveness Analysis By Region
- North America Market Analysis and Forecast, By Country, 2021 to 2036
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
- By Country
- United States
- Canada
- By Grade
- By Application
- By Country
- Market Attractiveness Analysis
- By Country
- By Grade
- By Application
- Key Takeaways
- Latin America Market Analysis and Forecast, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
- By Country
- Brazil
- Mexico
- Argentina
- Chile
- By Grade
- By Application
- By Country
- Market Attractiveness Analysis
- By Country
- By Grade
- By Application
- Key Takeaways
- Western Europe Market Analysis and Forecast, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
- By Country
- Germany
- France
- United Kingdom
- Italy
- Spain
- Benelux
- Nordics
- By Grade
- By Application
- By Country
- Market Attractiveness Analysis
- By Country
- By Grade
- By Application
- Key Takeaways
- Eastern Europe Market Analysis and Forecast, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
- By Country
- Poland
- Czech Republic
- Romania
- Hungary
- By Grade
- By Application
- By Country
- Market Attractiveness Analysis
- By Country
- By Grade
- By Application
- Key Takeaways
- East Asia Market Analysis and Forecast, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
- By Country
- China
- Japan
- South Korea
- By Grade
- By Application
- By Country
- Market Attractiveness Analysis
- By Country
- By Grade
- By Application
- Key Takeaways
- South Asia and Pacific Market Analysis and Forecast, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
- By Country
- India
- ASEAN
- Australia and New Zealand
- By Grade
- By Application
- By Country
- Market Attractiveness Analysis
- By Country
- By Grade
- By Application
- Key Takeaways
- Middle East and Africa Market Analysis and Forecast, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
- By Country
- GCC Countries
- South Africa
- Türkiye
- Israel
- By Grade
- By Application
- By Country
- Market Attractiveness Analysis
- By Country
- By Grade
- By Application
- Key Takeaways
- Key Countries Market Analysis
- United States
- Pricing Analysis
- Market Share Analysis, 2025
- By Grade
- By Application
- Canada
- Pricing Analysis
- Market Share Analysis, 2025
- By Grade
- By Application
- Mexico
- Pricing Analysis
- Market Share Analysis, 2025
- By Grade
- By Application
- Brazil
- Pricing Analysis
- Market Share Analysis, 2025
- By Grade
- By Application
- Chile
- Pricing Analysis
- Market Share Analysis, 2025
- By Grade
- By Application
- Germany
- Pricing Analysis
- Market Share Analysis, 2025
- By Grade
- By Application
- United Kingdom
- Pricing Analysis
- Market Share Analysis, 2025
- By Grade
- By Application
- Italy
- Pricing Analysis
- Market Share Analysis, 2025
- By Grade
- By Application
- Spain
- Pricing Analysis
- Market Share Analysis, 2025
- By Grade
- By Application
- France
- Pricing Analysis
- Market Share Analysis, 2025
- By Grade
- By Application
- India
- Pricing Analysis
- Market Share Analysis, 2025
- By Grade
- By Application
- ASEAN
- Pricing Analysis
- Market Share Analysis, 2025
- By Grade
- By Application
- Australia and New Zealand
- Pricing Analysis
- Market Share Analysis, 2025
- By Grade
- By Application
- China
- Pricing Analysis
- Market Share Analysis, 2025
- By Grade
- By Application
- Japan
- Pricing Analysis
- Market Share Analysis, 2025
- By Grade
- By Application
- South Korea
- Pricing Analysis
- Market Share Analysis, 2025
- By Grade
- By Application
- Poland
- Pricing Analysis
- Market Share Analysis, 2025
- By Grade
- By Application
- Hungary
- Pricing Analysis
- Market Share Analysis, 2025
- By Grade
- By Application
- Türkiye
- Pricing Analysis
- Market Share Analysis, 2025
- By Grade
- By Application
- South Africa
- Pricing Analysis
- Market Share Analysis, 2025
- By Grade
- By Application
- United States
- Market Structure Analysis
- Competition Dashboard
- Competition Benchmarking
- Market Share Analysis of Top Players
- By Regional
- By Grade
- By Application
- Emerging Startups
- Innovation Benchmarking
- Competition Analysis
- Competition Deep Dive
- gChem
- Overview
- Product Portfolio
- Profitability by Market Segments
- Sales Footprint
- Strategy Overview
- Marketing Strategy
- Product Strategy
- Channel Strategy
- Arkema
- Toray Fine Chemicals
- Hubei Xingfa
- Spectrum Chemical
- Shandong Haike
- Jiangsu Jiuyi
- Zibo Huixin
- Yichang Xinhua
- IRO Group
- Charkit Chemical
- Hefei TNJ
- Tokyo Chemical Industry
- gChem
- Case Studies
- Success Stories
- Recent Developments
- Competition Deep Dive
- Assumptions & Acronyms Used
